Sort
51,593 grants matching “hepatitis”
Rip Proteins in Innate Immune Signaling
$502,500Michelle Alice Kelliher · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · AI
Rip Proteins in Innate Immune Signaling
$502,500Michelle Alice Kelliher · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · AI
Rip Proteins in Innate Immune Signaling
$502,500Michelle Alice Kelliher · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · AI
dnTGF Beta RII Mice and PBC
$502,486Merrill E Gershwin · University Of California At Davis · R01 · FY2017 · DK
A TRIAL TO REDUCE HEPATITIS C AMONG INJECTION DRUG USERS
$502,458Rhode Island Hospital (Providence, Ri) · R01 · FY2002 · DA
Using the Preimplantation Factor (PIF) to Treat Graft-versus-Host Disease
$502,389Asaf Alimardanov · National Center For Advancing Translational Sciences · ZIA · FY2018 · TR
dnTGF Beta RII Mice and PBC
$502,329Merrill E Gershwin · University Of California At Davis · R01 · FY2015 · DK
gamma-OHPdG as a prognostic biomarker of HCC recurrence and its prevention
$502,311Fung-Lung Chung · Georgetown University · U01 · FY2019 · CA
Pathobiology of Hepatic Epithelia
$502,208Nicholas F. Larusso · Mayo Clinic Rochester · R01 · FY2007 · DK
PCSK9, Lipoprotein receptors, and Atherosclerosis
$502,190Sergio Fazio · Vanderbilt University · R01 · FY2012 · HL
Vaccine and Treatment Evaluation Unit at Saint Louis University
$502,177Daniel F. Hoft · Saint Louis University · UM1 · FY2021 · AI
Antiviral activity of Peg-IFN alpha in chronic HIV-1
$502,174Luis J. Montaner · Wistar Institute · U01 · FY2009 · AI
Scavenger Receptors: Ligand Binding and Pathophysiology
$502,144Monty Krieger · Massachusetts Institute Of Technology · R01 · FY2010 · HL
Molecular Mechanisms of Chemoprevention: Dithiolethiones
$502,144Thomas W Kensler · Johns Hopkins University · R01 · FY2008 · CA
DETERMINANTS OF HEPATITIS C &E MORBIDITY IN EGYPT
$502,136University Of Maryland Baltimore · U01 · FY2003 · AI
Role of Forkhead Proteins in Insulin Action
$502,082Domenico Accili · Columbia University Health Sciences · R01 · FY2011 · DK
San Diego Cirrhosis Clinical Research Network
$502,075Rohit Loomba · University Of California, San Diego · U01 · FY2023 · DK
dnTGF Beta RII Mice and PBC
$502,072Merrill E Gershwin · University Of California At Davis · R01 · FY2016 · DK
Identification of metabolic regulators of glycerolipid synthesis and storage
$502,049Kivanc Birsoy · Rockefeller University · R01 · FY2020 · DK
From humans and eukaryotes to viruses and pathogens; how transition metals shape catalysis and allostery
$502,043Maria-Eirini Pandelia · Brandeis University · R35 · FY2025 · GM
The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials Network
$502,021Jose Szapocznik · University Of Miami School Of Medicine · UG1 · FY2016 · DA
Tumor-promoting and tumor-suppressive roles of Hepatic Stellate Cell Subpopulations in NASH-HCC
$501,946Robert F. Schwabe · Columbia University Health Sciences · R01 · FY2023 · CA
Role of STING in Cholestatic Liver Injury
$501,915Shannon Stroud Glaser · Texas A&M University Health Science Ctr · R01 · FY2023 · DK
Cellular Roles in Liver Pathology: Dioxin as Prototype
$501,797University Of Wisconsin Madison · R01 · FY2005 · ES
Yale Drug Abuse, Addiction, and HIV Research Scholars (Yale-DAHRS)
$501,788Gail D'onofrio · Yale University · K12 · FY2014 · DA